<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39407839</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>The Model for End-Stage Liver Disease (MELD) Score Predicting Mortality Due to SARS-CoV-2 in Mexican Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5777</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13195777</ELocationID><Abstract><AbstractText><b>Background/Objectives</b>: Coronavirus Disease 2019 (COVID-19) can cause liver injury and a deterioration of hepatic function. The Model for End-Stage Liver Disease (MELD) score is a good predictor for poor prognosis of hospitalized COVID-19 patients in the United States, Egypt and Turkey. Nevertheless, the best cut-off value for the MELD score to predict mortality in the Mexican population has yet to be established. <b>Methods</b>: A total of 234 patients with COVID-19 were studied in a tertiary-level hospital. Patients were stratified into survivors (<i>n</i> = 139) and non-survivors (<i>n</i> = 95). Receiver operating characteristic curves, Cox proportional hazard models, Kaplan-Meier method, and Bonferroni corrections were performed to identify the predictors of COVID-19 mortality. <b>Results</b>: MELD score had an area under the curve of 0.62 (95% CI: 0.56-0.68; <i>p</i> = 0.0009), sensitivity = 53.68%, and specificity = 73.38%. Univariate Cox proportional hazard regression analysis suggested that the leukocytes &gt; 10.6, neutrophils &gt; 8.42, neutrophil-to-lymphocyte ratio (NLR) &gt; 8.69, systemic immune-inflammation index (SII) &gt; 1809.21, MELD score &gt; 9, and leukocyte glucose index (LGI) &gt; 2.41 were predictors for mortality. However, the multivariate Cox proportional hazard model revealed that only the MELD score &gt;9 (Hazard Ratio [HR] = 1.83; 95% confidence interval [CI]: 1.2-2.8; <i>P</i><sub>corrected</sub> = 0.03) was an independent predictor for mortality of COVID-19. <b>Conclusions</b>: Although the MELD score is used for liver transplantation, we suggest that a MELD score &gt;9 could be an accurate predictor for COVID-19 mortality at admission to ICU requiring mechanical ventilation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reyes-Ruiz</LastName><ForeName>José Manuel</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-2379-8591</Identifier><AffiliationInfo><Affiliation>Unidad Médica de Alta Especialidad, Hospital de Especialidades No. 14, Centro Médico Nacional "Adolfo Ruiz Cortines", Instituto Mexicano del Seguro Social (IMSS), Veracruz 91897, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avelino-Santiago</LastName><ForeName>Ana Citlali</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Unidad Médica de Alta Especialidad, Hospital de Especialidades No. 14, Centro Médico Nacional "Adolfo Ruiz Cortines", Instituto Mexicano del Seguro Social (IMSS), Veracruz 91897, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martínez-Mier</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unidad Médica de Alta Especialidad, Hospital de Especialidades No. 14, Centro Médico Nacional "Adolfo Ruiz Cortines", Instituto Mexicano del Seguro Social (IMSS), Veracruz 91897, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>López-López</LastName><ForeName>Claudia Vanessa</ForeName><Initials>CV</Initials><AffiliationInfo><Affiliation>Facultad de Medicina, Complejo Regional Sur Tehuacán, Benemérita Universidad Autónoma de Puebla (BUAP), Puebla 7585, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programa Interinstitucional para el Fortalecimiento de la Investigación y el Posgrado del Pacífico (Programa Delfín), Tepic 63000, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Jesús-González</LastName><ForeName>Luis Adrián</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0003-1415-6260</Identifier><AffiliationInfo><Affiliation>Unidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social, Zacatecas 98000, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>León-Juárez</LastName><ForeName>Moises</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5726-5953</Identifier><AffiliationInfo><Affiliation>Laboratorio de Virología Perinatal y Diseño Molecular de Antígenos y Biomarcadores, Departamento de Inmunobioquimica, Instituto Nacional de Perinatología, Mexico City 11000, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osuna-Ramos</LastName><ForeName>Juan Fidel</ForeName><Initials>JF</Initials><Identifier Source="ORCID">0000-0001-8280-9812</Identifier><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad Autónoma de Sinaloa, Culiacán 80019, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farfan-Morales</LastName><ForeName>Carlos Noe</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Departamento de Ciencias Naturales, Universidad Autónoma Metropolitana (UAM), Unidad Cuajimalpa, Mexico City 05348, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (CINVESTAV-IPN), Mexico City 07360, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palacios-Rápalo</LastName><ForeName>Selvin Noé</ForeName><Initials>SN</Initials><Identifier Source="ORCID">0000-0002-2184-6529</Identifier><AffiliationInfo><Affiliation>Institut Pasteur, Unité de Virologie Structurale, 75015 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernal-Dolores</LastName><ForeName>Víctor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Unidad Médica de Alta Especialidad, Hospital de Especialidades No. 14, Centro Médico Nacional "Adolfo Ruiz Cortines", Instituto Mexicano del Seguro Social (IMSS), Veracruz 91897, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Ángel</LastName><ForeName>Rosa María</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0002-6785-2035</Identifier><AffiliationInfo><Affiliation>Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (CINVESTAV-IPN), Mexico City 07360, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">model for end-stage liver disease (MELD) score</Keyword><Keyword MajorTopicYN="N">mortality</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39407839</ArticleId><ArticleId IdType="pmc">PMC11477146</ArticleId><ArticleId IdType="doi">10.3390/jcm13195777</ArticleId><ArticleId IdType="pii">jcm13195777</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kumar A., Singh R., Kaur J., Pandey S., Sharma V., Thakur L., Sati S., Mani S., Asthana S., Sharma T.K., et al. Wuhan to World: The COVID-19 Pandemic. Front. Cell. Infect. Microbiol. 2021;11:596201. doi: 10.3389/fcimb.2021.596201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.596201</ArticleId><ArticleId IdType="pmc">PMC8042280</ArticleId><ArticleId IdType="pubmed">33859951</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F., Chen W., Chen J., Xu D., Xie W., Wang X., Xie Y. Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases. Ann. Hepatol. 2021;21:100267. doi: 10.1016/j.aohep.2020.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aohep.2020.09.011</ArticleId><ArticleId IdType="pmc">PMC7548062</ArticleId><ArticleId IdType="pubmed">33053426</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan K., Samuel K., Vandeputte M., Hayes P.C., Plevris J.N. SARS-CoV-2 Infection and the Liver. Pathogens. 2020;9:430. doi: 10.3390/pathogens9060430.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9060430</ArticleId><ArticleId IdType="pmc">PMC7350360</ArticleId><ArticleId IdType="pubmed">32486188</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan A., Prichett L., Tao X., Alqahtani S.A., Hamilton J.P., Mezey E., Strauss A.T., Kim A., Potter J.J., Chen P.-H., et al. Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients. World J. Gastroenterol. 2022;28:570–587. doi: 10.3748/wjg.v28.i5.570.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v28.i5.570</ArticleId><ArticleId IdType="pmc">PMC8905016</ArticleId><ArticleId IdType="pubmed">35316959</ArticleId></ArticleIdList></Reference><Reference><Citation>Alva N.V., Méndez O.R., Gasca J.C., Salvador I., Hernández N., Valdez M. Liver injury due to COVID-19 in critically ill adult patients. A retrospective study. Rev. Gastroenterol. Mex. (Engl. Ed.) 2024;89:57–63. doi: 10.1016/j.rgmxen.2023.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rgmxen.2023.04.002</ArticleId><ArticleId IdType="pmc">PMC10110936</ArticleId><ArticleId IdType="pubmed">37117133</ArticleId></ArticleIdList></Reference><Reference><Citation>Licata A., Minissale M.G., Distefano M., Montalto G. Liver injury, SARS-CoV-2 infection and COVID-19: What physicians should really know? GastroHep. 2021;3:121–130. doi: 10.1002/ygh2.455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ygh2.455</ArticleId><ArticleId IdType="pmc">PMC8207035</ArticleId><ArticleId IdType="pubmed">34149320</ArticleId></ArticleIdList></Reference><Reference><Citation>Singal A.K., Kamath P.S. Model for End-stage Liver Disease. J. Clin. Exp. Hepatol. 2013;3:50–60. doi: 10.1016/j.jceh.2012.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jceh.2012.11.002</ArticleId><ArticleId IdType="pmc">PMC3940492</ArticleId><ArticleId IdType="pubmed">25755471</ArticleId></ArticleIdList></Reference><Reference><Citation>Stawinski P.M., Dziadkowiec K.N., Al-Abbasi B., Suarez L., Simms L., Dewaswala N., Torres P., Al Rubaye A., Pino J., Marcus A. Model of End-Stage Liver Disease (MELD) Score as a Predictor of In-Hospital Mortality in Patients with COVID-19: A Novel Approach to a Classic Scoring System. Cureus. 2021;13:e15179. doi: 10.7759/cureus.15179.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.15179</ArticleId><ArticleId IdType="pmc">PMC8216703</ArticleId><ArticleId IdType="pubmed">34178500</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya Y., Gülcü O., Aksakal E., Kalkan K., Aydın Ş., Kaya A., Bostan S. A significant predictor of in-hospital and long-term mortality and progression in COVID-19 patients: The end-stage liver disease (MELD) score model. J. Med. Virol. 2023;95:e28109. doi: 10.1002/jmv.28109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28109</ArticleId><ArticleId IdType="pmc">PMC9539042</ArticleId><ArticleId IdType="pubmed">36043339</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Samiee M., Shaldoum M., Abdelsameea E., Awad S.M., Omar N.A. Impact of COVID-19 on Liver Functions Tests in Egyptian Patients with or without Chronic Liver Disease. Afro-Egypt J. Infect. Endem Dis. 2024;14:75–84. doi: 10.21608/aeji.2024.262584.1350.</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/aeji.2024.262584.1350</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes-Ruiz J.M., García-Hernández O., Martínez-Mier G., Osuna-Ramos J.F., De Jesús-González L.A., Farfan-Morales C.N., Palacios-Rápalo S.N., Cordero-Rivera C.D., Ordoñez-Rodríguez T., Ángel R.M.d. The Role of Aspartate Aminotransferase-to-Lymphocyte Ratio Index (ALRI) in Predicting Mortality in SARS-CoV-2 Infection. Microorganisms. 2023;11:2894. doi: 10.3390/microorganisms11122894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11122894</ArticleId><ArticleId IdType="pmc">PMC10745537</ArticleId><ArticleId IdType="pubmed">38138038</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemcioglu E., Davutoglu M., Catalbas R., Karabuga B., Kaptan E., Aypak A., Kalem A.K., Özdemir M., Yeşilova N.Y., A Kalkan E., et al. Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission. Future Virol. 2021;16:353–367. doi: 10.2217/fvl-2020-0319.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fvl-2020-0319</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D., Yang H., Yu H., Wang T., Chen Z., Yao R., Liang Z. Diagnostic Value of Hematological and Biochemical Parameters Combinations for Predicting Coronavirus Disease 2019 (COVID-19) in Suspected Patients. Am. J. Med. Sci. 2021;362:387–395. doi: 10.1016/j.amjms.2021.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2021.04.006</ArticleId><ArticleId IdType="pmc">PMC8058050</ArticleId><ArticleId IdType="pubmed">33894184</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J.B., Xu C., Zhang R.B., Wu M., Pan C.K., Li X.J., Wang Q., Zeng F., Zhu S. Associations of procalcitonin, C-reaction protein and neutrophil-to-lymphocyte ratio with mortality in hospitalized COVID-19 patients in China. Sci. Rep. 2020;10:15058. doi: 10.1038/s41598-020-72164-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-72164-7</ArticleId><ArticleId IdType="pmc">PMC7490259</ArticleId><ArticleId IdType="pubmed">32929124</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.P., Liu J.P., Tao W.Q., Li H.M. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int. Immunopharmacol. 2020;84:106504. doi: 10.1016/j.intimp.2020.106504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.106504</ArticleId><ArticleId IdType="pmc">PMC7152924</ArticleId><ArticleId IdType="pubmed">32304994</ArticleId></ArticleIdList></Reference><Reference><Citation>Fois A.G., Paliogiannis P., Scano V., Cau S., Babudieri S., Perra R., Ruzzittu G., Zinellu E., Pirina P., Carru C., et al. The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients. Molecules. 2020;25:5725. doi: 10.3390/molecules25235725.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25235725</ArticleId><ArticleId IdType="pmc">PMC7731255</ArticleId><ArticleId IdType="pubmed">33291581</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Hernández W.M., Soto L.F., Del Rosario-Trinidad M., Farfan-Morales C.N., De Jesús-González L.A., Martínez-Mier G., Osuna-Ramos J.F., Bastida-González F., Bernal-Dolores V., del Ángel R.M., et al. Leukocyte glucose index as a novel biomarker for COVID-19 severity. Sci. Rep. 2022;12:14956. doi: 10.1038/s41598-022-18786-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-18786-5</ArticleId><ArticleId IdType="pmc">PMC9438363</ArticleId><ArticleId IdType="pubmed">36056114</ArticleId></ArticleIdList></Reference><Reference><Citation>Serin I., Sari N.D., Dogu M.H., Acikel S.D., Babur G., Ulusoy A., Onar M.I., Gokce E.C., Altunok O., Mert F.Y., et al. A new parameter in COVID-19 pandemic: Initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality. J. Infect. Public Health. 2020;13:1664–1670. doi: 10.1016/j.jiph.2020.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.09.009</ArticleId><ArticleId IdType="pmc">PMC7526632</ArticleId><ArticleId IdType="pubmed">33071210</ArticleId></ArticleIdList></Reference><Reference><Citation>Ok F., Erdogan O., Durmus E., Carkci S., Canik A. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients. J. Med. Virol. 2021;93:786–793. doi: 10.1002/jmv.26300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26300</ArticleId><ArticleId IdType="pmc">PMC7405288</ArticleId><ArticleId IdType="pubmed">32662893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussein H.A.M., Thabet A.A., Wardany A.A., El-Adly A.M., Ali M., Hassan M.E.A., Abdeldayem M.A.B., Mohamed A.-R.M.A., Sobhy A., El-Mokhtar M.A., et al. SARS-CoV-2 outbreak: Role of viral proteins and genomic diversity in virus infection and COVID-19 progression. Virol. J. 2024;21:75. doi: 10.1186/s12985-024-02342-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-024-02342-w</ArticleId><ArticleId IdType="pmc">PMC10967059</ArticleId><ArticleId IdType="pubmed">38539202</ArticleId></ArticleIdList></Reference><Reference><Citation>Dessie Z.G., Zewotir T. Mortality-related risk factors of COVID-19: A systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect. Dis. 2021;21:855. doi: 10.1186/s12879-021-06536-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06536-3</ArticleId><ArticleId IdType="pmc">PMC8380115</ArticleId><ArticleId IdType="pubmed">34418980</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X., Wang K., Zuo P., Liu Y., Zhang M., Xie S., Zhang H., Chen X., Liu C. Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients—Indications for predictive, preventive, and personalized medical approach. EPMA J. 2020;11:139–145. doi: 10.1007/s13167-020-00208-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13167-020-00208-z</ArticleId><ArticleId IdType="pmc">PMC7224348</ArticleId><ArticleId IdType="pubmed">32419876</ArticleId></ArticleIdList></Reference><Reference><Citation>Citu C., Gorun F., Motoc A., Sas I., Gorun O.M., Burlea B., Tuta-Sas I., Tomescu L., Neamtu R., Malita D., et al. The Predictive Role of NLR, d-NLR, MLR, and SIRI in COVID-19 Mortality. Diagnostics. 2022;12:122. doi: 10.3390/diagnostics12010122.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12010122</ArticleId><ArticleId IdType="pmc">PMC8774862</ArticleId><ArticleId IdType="pubmed">35054289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghobadi H., Mohammadshahi J., Javaheri N., Fouladi N., Mirzazadeh Y., Aslani M.R. Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly and elderly COVID-19 patients. Front. Med. 2022;9:916453. doi: 10.3389/fmed.2022.916453.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.916453</ArticleId><ArticleId IdType="pmc">PMC9434555</ArticleId><ArticleId IdType="pubmed">36059829</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon P., Le Borgne P., Lefevbre F., Cipolat L., Remillon A., Dib C., Hoffmann M., Gardeur I., Sabah J., Kepka S., et al. Platelet-to-Lymphocyte Ratio (PLR) Is Not a Predicting Marker of Severity but of Mortality in COVID-19 Patients Admitted to the Emergency Department: A Retrospective Multicenter Study. J. Clin. Med. 2022;11:4903. doi: 10.3390/jcm11164903.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11164903</ArticleId><ArticleId IdType="pmc">PMC9409988</ArticleId><ArticleId IdType="pubmed">36013142</ArticleId></ArticleIdList></Reference><Reference><Citation>Eslamijouybari M., Heydari K., Maleki I., Moosazadeh M., Hedayatizadeh-Omran A., Vahedi L., Ghasemian R., Sharifpour A., Alizadeh-Navaei R. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19 Patients and Control Group and Relationship with Disease Prognosis. Casp. J. Intern. Med. 2020;11((Suppl. S1)):531–535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7780872</ArticleId><ArticleId IdType="pubmed">33425271</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousavi S.A., Rad S., Rostami T., Rostami M., Mousavi S.A., Mirhoseini S.A., Kiumarsi A. Hematologic predictors of mortality in hospitalized patients with COVID-19: A comparative study. Hematology. 2020;25:383–388. doi: 10.1080/16078454.2020.1833435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/16078454.2020.1833435</ArticleId><ArticleId IdType="pubmed">33124971</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S., Kannan S., Khanna P., Singh A.K. Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: A systematic review and meta-analysis. J. Med. Virol. 2022;94:211–221. doi: 10.1002/jmv.27297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27297</ArticleId><ArticleId IdType="pmc">PMC8661888</ArticleId><ArticleId IdType="pubmed">34436785</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanner N., Andrieux G., Badia-i-Mompel P., Edler C., Pfefferle S., Lindenmeyer M.T., Schmidt-Lauber C., Czogalla J., Wong M.N., Okabayashi Y., et al. Molecular consequences of SARS-CoV-2 liver tropism. Nat. Metab. 2022;4:310–319. doi: 10.1038/s42255-022-00552-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-022-00552-6</ArticleId><ArticleId IdType="pmc">PMC8964418</ArticleId><ArticleId IdType="pubmed">35347318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Z.Y., Li G.X., Chen L., Shu C., Song J., Wang W., Wang Y., Chen Q., Jin G., Liu T., et al. Association of liver abnormalities with in-hospital mortality in patients with COVID-19. J. Hepatol. 2021;74:1295–1302. doi: 10.1016/j.jhep.2020.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.12.012</ArticleId><ArticleId IdType="pmc">PMC7749734</ArticleId><ArticleId IdType="pubmed">33347952</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Sulkowski M., Barin B., Stablein D., Curry M., Nissen N., Dove L., Roland M., Florman S., Blumberg E., et al. MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology. 2010;138:159–164. doi: 10.1053/j.gastro.2009.09.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2009.09.053</ArticleId><ArticleId IdType="pmc">PMC2826170</ArticleId><ArticleId IdType="pubmed">19800334</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt A.A., Ren Y., Lo Re V.I.I.I., Taddei T.H., Kaplan D.E. Comparing Child-Pugh, MELD, and FIB-4 to Predict Clinical Outcomes in Hepatitis C Virus-Infected Persons: Results From ERCHIVES. Clin. Infect. Dis. 2017;65:64–72. doi: 10.1093/cid/cix224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix224</ArticleId><ArticleId IdType="pubmed">28369305</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor R.M., Davern T., Munoz S., Han S.-H., McGuire B., Larson A.M., Hynan L., Lee W.M., Fontana R.J., U.S. Acute Liver Failure Study Group Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. Hepatology. 2006;44:1589–1597. doi: 10.1002/hep.21439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.21439</ArticleId><ArticleId IdType="pmc">PMC3505613</ArticleId><ArticleId IdType="pubmed">17133489</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>